Aptamere für Nukleare Translokation
EP4803628
9. September 2026
Anmelder: Tyris Therapeutics, S.L. 🇪🇸
Details
- Veröffentlichungs-Nr.
- EP4803628
- Anmeldetag
- 5. März 2025
- Veröffentlichung
- 9. September 2026
- Rechtsraum
- EP
- IPC
- C12N15/115, C12N15/113
Abstract
The present invention refers to an oligonucleotide sequences capable of translocating to the cell nucleus. Also provided are conjugates and constructs containing said oligonucleotides for cell delivery, preferably for nuclear cell delivery, and related therapeutic applications.
Anmelder
- Firma
- Tyris Therapeutics, S.L.
- Land
- 🇪🇸 Spanien